Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (251-260 of 420) with videos related to

Pageof 42
Sort By:
Open Forum Infectious Diseases|April 14, 2025
Frequency, Antimicrobial Susceptibility, and Molecular Characterization of Carbapenem-Resistant Enterobacterales Stratified by United States Census Divisions: Results From the INFORM Program (2018-2022)Helio S Sader, John H Kimbrough, Timothy B Doyle, et al.
International Journal of Antimicrobial Agents|December 27, 2017
Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016)Michael A Pfaller, Robert K Flamm, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease|March 5, 2003
Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterizationSoraya Andrade-Baiocchi, Maria Cristina B Tognim, Otavio C G Baiocchi, et al.
International Journal of Antimicrobial Agents|March 24, 2005
Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agentsSudha Pottumarthy, Thomas R Fritsche, Helio S Sader, et al.
International Journal of Antimicrobial Agents|September 21, 2021
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitalsMariana Castanheira, Timothy B Doyle, Lalitagauri M Deshpande, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|August 9, 2020
Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Comparators Tested Against <i>Pseudomonas aeruginosa</i> and <i>Klebsiella pneumoniae</i> Isolates from United States Medical Centers in 2016-2018Helio S Sader, Cecilia G Carvalhaes, Jennifer M Streit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010)David J Farrell, Mariana Castanheira, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2020
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against European Gram-negative bacterial surveillance isolates collected during 2012-18Helio S Sader, Cecilia G Carvalhaes, Leonard R Duncan, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 22, 2023
Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021)Helio S Sader, Cecilia G Carvalhaes, Michael D Huband, et al.
Journal of Global Antimicrobial Resistance|July 27, 2025
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus of diverse genetic typesMarisa L Winkler, John H Kimbrough, Helio S Sader, et al.
Pageof 42

Showing results (251-260 of 420) with videos related to

Sort By:
Pageof 42
Open Forum Infectious Diseases|April 14, 2025
Frequency, Antimicrobial Susceptibility, and Molecular Characterization of Carbapenem-Resistant Enterobacterales Stratified by United States Census Divisions: Results From the INFORM Program (2018-2022)Helio S Sader, John H Kimbrough, Timothy B Doyle, et al.
International Journal of Antimicrobial Agents|December 27, 2017
Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016)Michael A Pfaller, Robert K Flamm, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease|March 5, 2003
Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterizationSoraya Andrade-Baiocchi, Maria Cristina B Tognim, Otavio C G Baiocchi, et al.
International Journal of Antimicrobial Agents|March 24, 2005
Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agentsSudha Pottumarthy, Thomas R Fritsche, Helio S Sader, et al.
International Journal of Antimicrobial Agents|September 21, 2021
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitalsMariana Castanheira, Timothy B Doyle, Lalitagauri M Deshpande, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|August 9, 2020
Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Comparators Tested Against <i>Pseudomonas aeruginosa</i> and <i>Klebsiella pneumoniae</i> Isolates from United States Medical Centers in 2016-2018Helio S Sader, Cecilia G Carvalhaes, Jennifer M Streit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010)David J Farrell, Mariana Castanheira, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2020
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against European Gram-negative bacterial surveillance isolates collected during 2012-18Helio S Sader, Cecilia G Carvalhaes, Leonard R Duncan, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 22, 2023
Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021)Helio S Sader, Cecilia G Carvalhaes, Michael D Huband, et al.
Journal of Global Antimicrobial Resistance|July 27, 2025
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus of diverse genetic typesMarisa L Winkler, John H Kimbrough, Helio S Sader, et al.
Pageof 42